These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17401524)
1. A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland. Colville S; Swingler RJ; Grant IS; Williams FL J Neurol; 2007 Apr; 254(4):453-8. PubMed ID: 17401524 [TBL] [Abstract][Full Text] [Related]
2. Venous serum chloride and bicarbonate measurements in the evaluation of respiratory function in motor neuron disease. Hadjikoutis S; Wiles CM QJM; 2001 Sep; 94(9):491-5. PubMed ID: 11528013 [TBL] [Abstract][Full Text] [Related]
3. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. Capozzo R; Quaranta VN; Pellegrini F; Fontana A; Copetti M; Carratù P; Panza F; Cassano A; Falcone VA; Tortelli R; Cortese R; Simone IL; Resta O; Logroscino G J Neurol; 2015 Mar; 262(3):593-603. PubMed ID: 25522696 [TBL] [Abstract][Full Text] [Related]
4. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. Jackson CE; Rosenfeld J; Moore DH; Bryan WW; Barohn RJ; Wrench M; Myers D; Heberlin L; King R; Smith J; Gelinas D; Miller RG J Neurol Sci; 2001 Oct; 191(1-2):75-8. PubMed ID: 11676995 [TBL] [Abstract][Full Text] [Related]
5. Factors related to respiration influencing survival and respiratory function in patients with amyotrophic lateral sclerosis: a retrospective study. Leonardis L; Dolenc Grošelj L; Vidmar G Eur J Neurol; 2012 Dec; 19(12):1518-24. PubMed ID: 22594630 [TBL] [Abstract][Full Text] [Related]
6. Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan-Torin respiratory score (Mi-To-RS). Schito P; Manera U; Russo T; Cremona G; Riboldi E; Tettamanti A; Agosta F; Quattrini A; Chiò A; Filippi M; Calvo A; Riva N Eur J Neurol; 2024 Aug; 31(8):e16316. PubMed ID: 38716751 [TBL] [Abstract][Full Text] [Related]
7. [Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival]. Velasco R; Salachas F; Munerati E; Le Forestier N; Pradat PF; Lacomblez L; Orvoen Frija E; Meininger V Rev Neurol (Paris); 2002 May; 158(5 Pt 1):575-8. PubMed ID: 12072825 [TBL] [Abstract][Full Text] [Related]
8. Nocturnal oximetry: utility in the respiratory management of amyotrophic lateral sclerosis. Elman LB; Siderowf AD; McCluskey LF Am J Phys Med Rehabil; 2003 Nov; 82(11):866-70. PubMed ID: 14566155 [TBL] [Abstract][Full Text] [Related]
9. [Respiratory domain of revised amyotrophic lateral sclerosis. Functional Rating Scale]. Lima SE; Pessolano FA; Monteiro SG; De Vito EL Medicina (B Aires); 2009; 69(5):547-53. PubMed ID: 19897441 [TBL] [Abstract][Full Text] [Related]
10. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Morgan RK; McNally S; Alexander M; Conroy R; Hardiman O; Costello RW Am J Respir Crit Care Med; 2005 Feb; 171(3):269-74. PubMed ID: 15516537 [TBL] [Abstract][Full Text] [Related]
11. Motor neurone disease--a study of prevalence and disability. James CM; Harper PS; Wiles CM QJM; 1994 Nov; 87(11):693-9. PubMed ID: 7820544 [TBL] [Abstract][Full Text] [Related]
12. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Lewis CA; Fergusson W; Eaton T; Zeng I; Kolbe J Thorax; 2009 Feb; 64(2):133-8. PubMed ID: 18390630 [TBL] [Abstract][Full Text] [Related]
13. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653 [TBL] [Abstract][Full Text] [Related]
14. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Chaudri MB; Liu C; Watson L; Jefferson D; Kinnear WJ Eur Respir J; 2000 Mar; 15(3):539-42. PubMed ID: 10759449 [TBL] [Abstract][Full Text] [Related]
15. Respiratory management of motor neurone disease: a review of current practice and new developments. Rafiq MK; Proctor AR; McDermott CJ; Shaw PJ Pract Neurol; 2012 Jun; 12(3):166-76. PubMed ID: 22661348 [TBL] [Abstract][Full Text] [Related]
16. Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral. Raaphorst J; Tuijp J; Verweij L; Westermann EJ; van der Kooi AJ; Gaytant MA; van den Berg LH; de Visser M; Kampelmacher MJ Eur J Neurol; 2013 Dec; 20(12):1524-30. PubMed ID: 23398243 [TBL] [Abstract][Full Text] [Related]
17. Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis. Volanti P; Cibella F; Sarvà M; De Cicco D; Spanevello A; Mora G; La Bella V J Neurol Sci; 2011 Apr; 303(1-2):114-8. PubMed ID: 21276597 [TBL] [Abstract][Full Text] [Related]
18. Assessment of respiratory muscle strength in motor neurone disease: is asking enough? Murphy P; Lyall R; Hart N; Polkey MI Eur Respir J; 2010 Feb; 35(2):245-6. PubMed ID: 20123844 [No Abstract] [Full Text] [Related]
19. Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation. de Carvalho M; Costa J; Pinto S; Pinto A Amyotroph Lateral Scler; 2009 Jun; 10(3):154-61. PubMed ID: 18763180 [TBL] [Abstract][Full Text] [Related]
20. Current issues in the respiratory care of patients with amyotrophic lateral sclerosis. Orsini M; Lopes AJ; Menezes SL; Oliveira AB; Freitas MR; Nascimento OJ; Guimarães FS Arq Neuropsiquiatr; 2015 Oct; 73(10):873-6. PubMed ID: 26331388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]